Wockhardt had its share of problems this year. It finished the year on a disappointing note. Profits in the fourth quarter plunged 43.20 per cent. Sales too declined marginally.
Disputes with the Federation of Medical Representatives Association of India (FMRAI), coupled with degrowth in the vaccines business, hit the company
